Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...
Үндсэн зохиолчид: | Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere |
---|---|
Формат: | Өгүүллэг |
Хэл сонгох: | English |
Хэвлэсэн: |
Taylor & Francis Group
2017-04-01
|
Цуврал: | Expert Review of Vaccines |
Нөхцлүүд: | |
Онлайн хандалт: | http://dx.doi.org/10.1080/14760584.2017.1294068 |
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
-н: Piyada Angsuwatcharakon, зэрэг
Хэвлэсэн: (2018-02-01) -
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
-н: Jia Li, зэрэг
Хэвлэсэн: (2024-12-01) -
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
-н: D.J. Briggs, зэрэг -
Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
-н: Jing Wang, зэрэг
Хэвлэсэн: (2017-01-01) -
DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
-н: A. L. Kravtsov, зэрэг
Хэвлэсэн: (2019-08-01)